Moniz Calls on Global Leaders to Work to Reduce Risks Associated with Biotechnologies
NTI Co-Chair and CEO work urgently to reduce biological risks associated with advances in technology.
NTI Co-Chair and CEO work urgently to reduce biological risks associated with advances in technology.
NTI CEO Ernest J. Moniz spoke with the New Hampshire World Affairs Council in Manchester about today's emerging nuclear threats.
The Time is 100 Seconds to Midnight
NTI Seminar: Wilmot James on Epidemics in Complex Environments
The demand for presidential candidates to address the risks posed by nuclear weapons cuts across party lines.
Past Event
Ted Turner Board Room, NTI
New Report Summarizes “Paper to Practice” Outcomes in Nuclear Disarmament Verification
Advancements in commercially available DNA synthesis technologies pose growing risks, with the potential to cause catastrophic biosecurity threats if misused.
Sign up for regular updates on innovative, real-world solutions to existential threats.
{ location = 'https://www.nti.org/get-updates/' }, 300);">Get Updates